The economic costs of illicit drug use in Ontario, 1992

Health Economics

Volumn 7, Issue 1, 1998, Pages 81-85

  Xie, Xiaodi ^a   Rehrn, Jürgen ^b   Single, Eric ^c   Robson, Lynda ^d   Paul, Josh ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Canadian Centre on Substance Use and Addiction   (Canada)

^d INSTITUTE FOR WORK AND HEALTH   (Canada)

Author keywords

Canada; Cost of illness; Economic cost; Illicit drugs; Ontario

Indexed keywords

ILLICIT DRUG;

ARTICLE; CANADA; COST OF ILLNESS; DEATH; DRUG ABUSE; ECONOMIC EVALUATION; HEALTH CARE COST; HOSPITALIZATION; HUMAN; METHODOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HOSPITAL;

COST OF ILLNESS; EMPLOYMENT; HUMANS; ONTARIO; PREVALENCE; SOCIAL PROBLEMS; SUBSTANCE-RELATED DISORDERS;

EID: 0031888959     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1050(199802)7:1<81::AID-HEC330>3.0.CO;2-I     Document Type: Article

References (25)

1. Robson, L. and Single, E. Literature review of studies on the economic costs of substance abuse. Ottawa: CCSA, 1995.
2. Adrian, M., Jull, P. and Williams, R.T. Statistics on alcohol and drug use in Canada and other countries. Toronto: Addiction Research Foundation, 1988.
3. Coordinated Law Enforcement Unit. The costs associated with illicit drug use in British Columbia in 1989. British Columbia: Ministry of Attorney General, 1992.
4. Collins, D. and Lapsley, H. Estimating the economic costs of drug abuse in Australia, National Campaign Against Drug Abuse. Canberra: Commonwealth of Australia, 1991.
5. Fazey, C.S.J. and Stevenson, R.C. The social and economic costs of drug abuse in the UK and the Netherlands. London: Commission of the European Communities, 1990.
6. Institut suisse de prophylaxie de l'alcoolisme. Le probleme de la drogue. Lausanne: Office federal de la sante publique, 1990.
7. Single, E., Easton, B., Collins, D., Harwood, H., Lapsley, H. and Maynard, A. Proposed international guidelines for estimating the costs of substance abuse. Ottawa: Canadian Centre on Substance Abuse, 1995.
8. Rice, D. Estimating the cost of illness. Health Economics Series, Number 6. DHEW Pub. No. (PHS)947-6. Rockville, MD: US Department of Health, Education and Welfare, 1966.
9. Hodgson, T.A. and Meiners, M.R. Guidelines for cost of illness studies in the public health service. Task Force on Cost of Illness Studies. Washington: US Public Health Service, 1979.
10. Harwood, H.J., Napolitano, D.M., Kristiansen, P.L. and Collins, J.J. Economic costs to society of alcohol and drug abuse and mental illness: 1980. The Research Triangle Institute, 1984.
11. Rice, D., Kelman, S., Miller, L. and Dunmeyer, S. The economic cost of alcohol and drug abuse and mental illness 1985. DHHS Publication No. (ADM) 90-164. San Francisco, California: Office of Financing and Coverage Policy of the Alcohol, Drug Abuse, and Mental Health Administration, Institute for Health and Aging, 1990.
12. Hodgson, T.A. and Meiners, M.R. Cost-of-illness methodology: a guide to current practices and procedures. Millbank Memorial Fund Quarterly/Health and Society 1982; 60: 429-462.
13. Hodgson, T.A. The state of the art cost-of-illness estimates. Advances in Health Economics and Health Services Research 1983; 4: 129-164.
14. Rehm, J., Ialomiteanu, A., Walsh, G., Adlaf, E. and Single, E. The quantification of mortality caused by illicit drugs in Canada, 1992. Toronto: Addiction Research Foundation, 1996.
15. Alter, M.J., Coleman, P.J., Alexander, W.J., Kramer, E., Miller, J.K., Mandel, E., Hadler, S.C. and Margolis H.S. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. Journal of the American Medical Association 1989; 262: 1201-1205.
16. Alter, M.J., Hadler, S.C., Margolis, H.S., Alexander, W.J., Hu, P.Y., Judson, F.N., Mares, A., Miller, J.K. and Moyer, L.A. the changing epidemiology of hepatitis B in the United States. Journal of American Medical Association 1990; 263: 1218-1222.
17. English, D., Holman, D., Milne, E., Winter, M., Hulse, G., Codde, G., Bower, C., Corti, B., de Klerk, C., Lewin, G., Knuiman, M., Kurinczuk, J., Ryan, G. The quantification of drug caused morbidity and mortality in Australia, 1992. Canberra: Commonwealth Department of Human Services, 1995.
18. Xie, X., Rehm J., Single, E. and Robson, L. The economic costs of alcohol, tobacco and illicit drug abuse in Ontario: 1992. Toronto: Addiction Research Foundation, 1996.
19. Ellis, K. and Rush, B. Alcohol and other drug services in Ontario: results of a 1992 survey. Toronto: ARF, 1993.
20. MacDonald, S. and Wells, S. The prevalence and characteristics of employee assistance, health promotion and drug testing programs in Ontario. Employee Assistance Quarterly 1994, 10: 25-60.
21. Single, E., Robson, L., Xie, X. and Rehm, J. The costs of substance abuse in Canada. Toronto: Canadian Centre on Substance Abuse, 1996.
22. Xie, X., Rehm J., Single, E. and Robson, L. Selected economic consequences of substance abuse in Ontario: 1992. Toronto: Addiction Research Foundation, 1996.
23. Drummond, M. Cost-of-illness studies: a major headache? Pharmacoeconomics 1992; 2(1): 1-4.
24. Johannesson, M. and Karlsson, G. The friction cost method: a comment. Journal of Health Economics 1997; 16(2): 249-255.
25. Koopmanschap, M., Rutten, F., van Ineveld, B. and van Roijen, L. The friction cost method for estimating the indirect costs of disease. Journal of Health Economics 1995; 14: 171-189.